Non-invasive MR imaging using the elastin-specific molecular probe produced image data with a high spatial resolution and clear contrast enhancement in the viable tumor regions, thus underlining the priority of targeted MRI in hepatic cancer research. This evidence concerns the gene ELN and liver cancer.